RU-521

N/A

Report date: 2023/04/02 18:44:57
NME

Base Information

Drug NameRU-521
Drug Alias NameRU-521RU.521
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic GMP-AMP synthase inhibitors
TargetsCyclic GMP-AMP synthase
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A